drugset / Trial / NCT06451900

Role of Fenofibrate in Neonatal Jaundice

NCT06451900

Phase 4 Completed 75 enrolled Ain Shams University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Fenofibrate appears to be an effective and safe drug for the treatment of neonatal hyperbilirubinemia. It has been proven that it decreases the duration of phototherapy and thus shortens the length of hospital stay. This study was performed to study the prophylactic role of fenofibrate in prevention of neonatal jaundice.

Timeline

Start
2023-07-01
Primary completion
2023-11-20
Completion
2023-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenofibrate Small molecule 10 mg/kg Oral